Cambrex Corp. (CBM) Tops Q1 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Cambrex Reports First Quarter 2019 Financial Results
May 2, 2019 6:40 AM EDT- Acquired Avista Pharma Solutions, broadening capabilities, enhancing revenue growth and expanding customer base -
- Reaffirms full year financial guidance -
- Conference call at 8:30 a.m. ET on May 2, 2019 -
EAST RUTHERFORD, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, reports results for the first quarter ended March 31, 2019.
First Quarter 2019 Highlights
Completed the... More


